Cancer is one of the leading causes of death in dogs, with diagnosis ranging from lymphoma to mast cell tumors. A recent ...

The global mast cell tumor treatment market is on a strong growth trajectory, with market projections estimating a valuation of USD 7,836.4 million by 2034. This reflects a steady CAGR of 3.4% from ...

Caroline Cray from Boston is living with allergies so severe that she is only able to safely eat two foods. Her episodes began at two and escalated as she got older. After years of hospital visits, ...

Caroline Cray from Boston is living with allergies so severe that she is only able to safely eat two foods. Her episodes began at two and escalated as she got older. After years of hospital visits, ...

Histamine makes lots of changes in your body. It adjusts your blood vessels and tissues so more immune cells can rush to the area. It makes a bunch of mucus. It tells the muscles in your airways, ...

Allergic inflammation plays a big role in allergy reactions and contributes to the itching and chewing commonly seen with ...

At the recent AAAAI/WAO meeting, Blueprint Medicines Corp. presented the in vitro and in vivo characterization of BLU-808, a selective inhibitor of wild-type KIT, a transmembrane receptor tyrosine ...

THB-335 is an oral inhibitor of mast/stem cell growth factor receptor Kit (KIT), which regulates the activation and migration of mast cells, making it a relevant therapeutic target for inflammatory ...

Therapeutics announced positive preclinical data from CDX-622, a novel bispecific antibody that targets two non-redundant, ...

- CDX-622 inhibits SCF and TSLP-dependent inflammatory signatures in human skin - - Phase 1 study in healthy volunteers ongoing - ...

Red, blue and orange weather balloons flew high over King Pine Drive in Madison on Tuesday during a test to approximate visibility of a cell tower at that ...

BLU-808 achieved dose-dependent serum tryptase reductions exceeding 80 percent, reflecting evidence of mast cell target engagement. BLU-808 had a half-life supporting once-daily oral dosing and ...